At a glance
ClinicalIndex Comparison RecordN/ACompleted· 380 enrolled
Drug / intervention
Radical-7 Pulse CO-Oximeter and sensordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Non-Invasive Hemoglobin in Trauma Patients Using FDA-Cleared Masimo Pulse CO-Oximeter
In Brief
A clinical study evaluating Radical-7 Pulse CO-Oximeter and sensor for Trauma. Completed, enrolled 380 participants across 1 site.
Detailed Summary
This is a prospective, non-blinded, non-randomized, interventional study of the Masimo pulse oximeter and sensors in a trauma setting
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTrauma
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartJun 2016
Primary CompletionMar 2017
First PostedApr 2017
TodayJul 2026
First PostedApr 21, 2017
Enrollment StartJun 30, 2016
Primary CompletionMar 25, 2017
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 9.2 years ago
Interventions
Radical-7 Pulse CO-Oximeter and sensordevice
Noninvasive device that measures hemoglobin.